Inventor · disambiguated record
Veera Konda
Also filed as: KONDA VEERA · KONDA VEERA R
14 granted patents·17 pending applications·39 citations·filing 2006–2018
89Inventor score
Files withMETAPROTEOMICS LLC17TRIPP MATTHEW L7KINDEX PHARMACEUTICALS INC3CARROLL BRIAN J2METAPROTEOMICS LLP1
Top patents by PatentIndex Score
31 records- 0192US7736677B2Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Granted Jun 15, 2010·11 cites·3 claims
- 0289US8475850B2Methods and compositions for heavy metal detoxificationTRIPP MATTHEW L·Filed 2012·Granted Jul 2, 2013·6 cites·4 claims
- 0389US8206753B2Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetesTRIPP MATTHEW L·Filed 2006·Granted Jun 26, 2012·6 cites·4 claims
- 0482US7718198B2Treatment modalities for autoimmune diseasesMETAPROTEOMICS LLC·Filed 2006·Granted May 18, 2010·6 cites·8 claims
- 0578US8263139B2Protein kinase modulation by hops and Acacia productsTRIPP MATTHEW L·Filed 2006·Granted Sep 11, 2012·3 cites·5 claims
- 0678US7901714B2Treatment modalities for autoimmune diseasesMETAPROTEOMICS LLP·Filed 2007·Granted Mar 8, 2011·3 cites·8 claims
- 0774US8410178B2CIS 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methodsCARROLL BRIAN J·Filed 2011·Granted Apr 2, 2013·3 cites·17 claims
- 0872US8815306B2Methods and compositions for promoting bone and joint healthTRIPP MATTHEW L·Filed 2008·Granted Aug 26, 2014·1 cites·10 claims
- 0963US2008026088A1Reduced isoalpha acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 1063US2008033057A1Hexahydro-isoalpha acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 1163US2008031893A1Acacia based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 1263US2008031982A1Tetrahydro-isoalpha acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 1363US2008031894A1Beta acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 1463US2008033056A1Xanthohumol based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 1560US8241674B2Methods and compositions for heavy metal detoxificationTRIPP MATTHEW L·Filed 2008·Granted Aug 14, 2012·0 cites·12 claims
- 1660US2010069422A1Methods and compositions for promoting bone and joint healthMETAPROTEOMICS LLC·Filed 2009·Application pending·0 cites
- 1757US2008051466A1Isoalpha acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 1856US8829056B2Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl) cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methodsKINDEX PHARMACEUTICALS INC·Filed 2013·Granted Sep 9, 2014·0 cites·7 claims
- 1956US2013064913A1Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetesTRIPP MATTHEW L·Filed 2012·Application pending·0 cites
- 2054US2008031986A1Protein kinase modulation by hops and acacia productsMETAPROTEOMICS LLC·Filed 2007·Application pending·0 cites
- 2153US8410179B2Cis, 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methodsCARROLL BRIAN J·Filed 2012·Granted Apr 2, 2013·0 cites·13 claims
- 2252US2007154576A1Protein kinase modulation by hops and Acacia productsTRIPP MATTHEW L·Filed 2006·Application pending·0 cites
- 2351US2011021637A1Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatmentMETAPROTEOMICS LLC·Filed 2010·Application pending·0 cites
- 2449US2010222262A1Substituted 1, 3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactionsMETAPROTEOMICS LLC·Filed 2009·Application pending·0 cites
- 2549US2010137449A1Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewithMETAPROTEOMICS LLC·Filed 2008·Application pending·0 cites
- 2646US12194065B2Methods and compositions to enhance metabolic detoxification systemsNATURES SUNSHINE PRODUCTS INC·Filed 2018·Granted Jan 14, 2025·0 cites·18 claims
- 2746US10343977B2Tetrahydro-isohumulone derivatives, methods of making and usingKINDEX PHARMACEUTICALS INC·Filed 2017·Granted Jul 9, 2019·0 cites·1 claims
- 2846US2013337092A1Phytonutrient compositions and methods of useMETAPROTEOMICS LLC·Filed 2013·Application pending·0 cites
- 2937US9828331B2Tetrahydro-isohumulone derivatives, methods of making and usingKINDEX PHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·0 cites·1 claims
- 3037US2011135768A1Dihydro-isoalpha acid and acacia nilotica extract based compositions and methods for weight managementMETAPROTEOMICS LLC·Filed 2010·Application pending·0 cites
- 3137US2011136917A1Tetrahydro-isoalpha acid compositions and methods for weight managementMETAPROTEOMICS LLC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Veera Konda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →